EP-202

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameEP-202
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionTh1 cells stimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A